MedTrace Logo

Post Market Study of the 3DKnee™ With E-plus Insert

NCT01551472 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 175

Last updated 2022-03-31

No results posted yet for this study

Summary

The purpose of this study is to evaluate the use and efficacy of the 3DKnee™ System using Vitamin E UHMWPE tibial inserts for total knee replacement surgery.

Conditions

Interventions

DEVICE

3DKnee™ System with Vitamin E UHMWPE Tibial Inserts

This device is part of a total knee replacement system utilized in treating patients who are candidates for primary cemented total knee arthroplasty or revision arthroplasty where bone loss is minimal and the collateral ligaments are intact. It is intended to aid the surgeon in relieving the patient of knee pain and restoring knee joint function.

Sponsors & Collaborators

  • DJO Incorporated

    collaborator INDUSTRY

  • Encore Medical, L.P.

    lead INDUSTRY

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2022-01-31
Completion
2022-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01551472 on ClinicalTrials.gov